Population Genetics Technologies
closedPopulation Genetics develops technologies to characterize and quantify true genetic variants responsible for diseases and drug response.
Launch date
Market cap
-
Enterprise valuation
AUD2—4m (Dealroom.co estimates Mar 2013.)
Cambridge Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | Seed | |
| N/A | £3.8m | Series A | |
| N/A | $3.2m | Series A | |
€1.9m | Early VC | ||
$5.7m | Series B | ||
€1.3m | Series F | ||
€360k | Series G | ||
| Total Funding | AUD27.6m | ||